185 related articles for article (PubMed ID: 27056951)
1. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.
Castanha PM; Braga C; Cordeiro MT; Souza AI; Silva CD; Martelli CM; van Panhuis WG; Nascimento EJ; Marques ET
J Infect Dis; 2016 Jul; 214(2):265-72. PubMed ID: 27056951
[TBL] [Abstract][Full Text] [Related]
2. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
[TBL] [Abstract][Full Text] [Related]
3. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants.
Chau TN; Hieu NT; Anders KL; Wolbers M; Lien le B; Hieu LT; Hien TT; Hung NT; Farrar J; Whitehead S; Simmons CP
J Infect Dis; 2009 Dec; 200(12):1893-900. PubMed ID: 19911991
[TBL] [Abstract][Full Text] [Related]
4. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
[TBL] [Abstract][Full Text] [Related]
5. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil.
de Teive E Argolo AF; de Rezende Féres VC; Cordeiro MT; da Silveira LA; Guilarde AO; de Azevedo Marques ET; de Souza WV; Martelli CM
BMC Infect Dis; 2016 Oct; 16(1):546. PubMed ID: 27717314
[TBL] [Abstract][Full Text] [Related]
6. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
7. Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy.
Singh T; Lopez CA; Giuberti C; Dennis ML; Itell HL; Heimsath HJ; Webster HS; Roark HK; Merçon de Vargas PR; Hall A; Corey RG; Swamy GK; Dietze R; Lazear HM; Permar SR
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007648. PubMed ID: 31449521
[TBL] [Abstract][Full Text] [Related]
8. Force of infection of dengue serotypes in a population-based study in the northeast of Brazil.
Castanha PM; Cordeiro MT; Martelli CM; Souza WV; Marques ET; Braga C
Epidemiol Infect; 2013 May; 141(5):1080-8. PubMed ID: 22800513
[TBL] [Abstract][Full Text] [Related]
9. Dengue antibody in Thai children from maternally transferred antibody to acquired infection.
Pengsaa K; Limkittikul K; Yoksan S; Wisetsing P; Sabchareon A
Pediatr Infect Dis J; 2011 Oct; 30(10):897-900. PubMed ID: 21552182
[TBL] [Abstract][Full Text] [Related]
10. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.
Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K
BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study.
Guignard A; Haguinet F; Wéry S; Kerdpanich P
Asia Pac J Public Health; 2019 May; 31(4):288-295. PubMed ID: 31307216
[TBL] [Abstract][Full Text] [Related]
12. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
Moi ML; Takasaki T; Saijo M; Kurane I
Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
[TBL] [Abstract][Full Text] [Related]
13. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics.
Clapham H; Cummings DA; Nisalak A; Kalayanarooj S; Thaisomboonsuk B; Klungthong C; Fernandez S; Srikiatkhachorn A; Macareo LR; Lessler J; Reiser J; Yoon IK
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004262. PubMed ID: 26658730
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia.
Yamanaka A; Tabuchi Y; Mulyatno KC; Susilowati H; Hendrianto E; Soegijanto S; Konishi E
Microbes Infect; 2012 Nov; 14(13):1152-9. PubMed ID: 22841680
[TBL] [Abstract][Full Text] [Related]
17. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.
Puschnik A; Lau L; Cromwell EA; Balmaseda A; Zompi S; Harris E
PLoS Negl Trop Dis; 2013; 7(6):e2274. PubMed ID: 23785536
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children.
Pengsaa K; Luxemburger C; Sabchareon A; Limkittikul K; Yoksan S; Chambonneau L; Chaovarind U; Sirivichayakul C; Lapphra K; Chanthavanich P; Lang J
J Infect Dis; 2006 Dec; 194(11):1570-6. PubMed ID: 17083042
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
Andrade DV; Katzelnick LC; Widman DG; Balmaseda A; de Silva AM; Baric RS; Harris E
mBio; 2017 Sep; 8(5):. PubMed ID: 28928210
[TBL] [Abstract][Full Text] [Related]
20. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
